As prostate cancer is a biologically heterogeneous disease for which a variety of treatment options are available, the major objective of prostate cancer imaging is to achieve more precise disease characterization.
In clinical practice, magnetic resonance imaging (MRI) is one of the imaging tools for the evaluation of prostate cancer, the fusion of MRI or dynamic contrast-enhanced MRI (DCE-MRI) with magnetic resonance spectroscopic imaging (MRSI) is improving the evaluation of cancer location, size, and extent, while providing an indication of tumor aggressiveness. This review summarizes the role of MRI in the application of prostate cancer and describes molecular MRI techniques (including MRSI and DCE-MRI) for aiding prostate cancer management.
Written by:
Li B, Du Y, Yang H, Huang Y, Meng J, Xiao D. Are you the author?
Sichuan Key Laboratory of Medical Imaging, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China; Department of Radiology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China
Reference: Chin J Cancer Res. 2013 Apr;25(2):240-9.
doi: 10.3978/j.issn.1000-9604.2013.03.06
PubMed Abstract
PMID: 23592906
UroToday.com Prostate Cancer Section
